- Home
- CLST vs DYAI Comparison
CLST vs DYAI Comparison
Compare CLST & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- DYAI
- Stock Information
- Founded
- CLST 1922
- DYAI 1979
- Country
- CLST United States
- DYAI United States
- Employees
- CLST N/A
- DYAI N/A
- Industry
- CLST
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLST
- DYAI Health Care
- Exchange
- CLST Nasdaq
- DYAI Nasdaq
- Market Cap
- CLST 51.0M
- DYAI 54.4M
- IPO Year
- CLST N/A
- DYAI 2004
- Fundamental
- Price
- CLST $11.31
- DYAI $1.40
- Analyst Decision
- CLST
- DYAI Strong Buy
- Analyst Count
- CLST 0
- DYAI 1
- Target Price
- CLST N/A
- DYAI $6.00
- AVG Volume (30 Days)
- CLST 6.4K
- DYAI 38.0K
- Earning Date
- CLST 05-01-2025
- DYAI 03-27-2025
- Dividend Yield
- CLST N/A
- DYAI N/A
- EPS Growth
- CLST N/A
- DYAI N/A
- EPS
- CLST N/A
- DYAI N/A
- Revenue
- CLST $5,174,000.00
- DYAI $3,364,548.00
- Revenue This Year
- CLST N/A
- DYAI $51.30
- Revenue Next Year
- CLST N/A
- DYAI $73.26
- P/E Ratio
- CLST N/A
- DYAI N/A
- Revenue Growth
- CLST N/A
- DYAI 13.82
- 52 Week Low
- CLST $10.78
- DYAI $0.93
- 52 Week High
- CLST $12.10
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- CLST 27.40
- DYAI 44.20
- Support Level
- CLST $11.62
- DYAI $1.37
- Resistance Level
- CLST $11.78
- DYAI $1.54
- Average True Range (ATR)
- CLST 0.12
- DYAI 0.12
- MACD
- CLST -0.03
- DYAI -0.00
- Stochastic Oscillator
- CLST 17.09
- DYAI 28.57
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.